DMEMEDS shared post via Reuters: Novo Nordisk changes strategy in Germany, launches diabetes drug

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug Tresiba in Germany on May 1 after seeing signs of a more favourable pricing situation there. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/ssSCPl1czL8/story01.htm

Read More